Who
Jonathan Rubin
SVP, Chief Medical Officer
Company insider
Files Form 4 as: SVP, Chief Medical Officer, Supernus Pharmaceuticals.
In numbers
- Trades disclosed
- 87
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $36K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Feb 2021
- Last trade
- 12 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —750 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $17K363 at $46.57 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —750 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —750 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —750 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $17K363 at $46.57 | filing |
| 29 Jul 2026filed 31 Jul 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —750 at $0.00 | filing |
| 29 Jul 2026filed 31 Jul 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —750 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,250 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $34K675 at $50.69 | filing |
| 25 Feb 2026filed 26 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —1,250 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —1,250 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,250 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $34K675 at $50.69 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,125 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $31K603 at $51.35 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —750 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —1,125 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —750 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —1,250 at $0.00 | filing |
News
Supernus Pharmaceuticals (NASDAQ:SUPN) vs. Kiora Pharmaceuticals (NASDAQ:KPRX) Critical SurveySUPN · tickerreport.com · 11 Oct 2026Shineco (NASDAQ:SISI) vs. Supernus Pharmaceuticals (NASDAQ:SUPN) Financial AnalysisSUPN · dailypolitical.com · 8 Oct 2026Supernus Pharmaceuticals (NASDAQ:SUPN) vs. Harrow (NASDAQ:HROW) Head to Head ComparisonSUPN · themarketsdaily.com · 5 Oct 2026
0 headlines in the last 90 days name Jonathan Rubin; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.